Carole Ramacci

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti‐EGFR antibodies in colorectal cancer

Géraldine Perkins, Astrid Lièvre, Carole Ramacci et al. · International Journal of Cancer · 2010 · 48 citations · Full text

In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector

Gilles Dolivet, Jean‐Louis Merlin, Muriel Barberi‐Heyob et al. · Cancer Gene Therapy · 2002 · 33 citations

Tumor Biology, Oncogenic Agent, Neck Carcinoma Xenografts +9

Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies

J.L. Merlin, A Guerci, Stéphane Marchal et al. · Blood · 1994 · 32 citations · Full text

Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43°C hyperthermia in sensitive and multidrug-resistant MCF-7 cells

Jean‐Louis Merlin, Carole Ramacci, Dominique Notter et al. · European Journal of Cancer · 1993 · 25 citations

Nanomedicine, Medicinal Chemistry, Multidrug-resistant Mcf-7 Cells +10

P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab

Sanae Bouali, Anne-Sophie Chrétien, Carole Ramacci et al. · Cancer Gene Therapy · 2009 · 23 citations

Tumor Biology, Signaling Pathway, Cell Regulation +10